Clinical trials: Benign Prostatic Hypertrophy Requiring Surgical Intervention
Benign Prostatic Hypertrophy Requiring Surgical Intervention
Randomized Controlled Trial Comparing Two Different Morcellators for HoLEP Procedures
To compare efficiency, in terms of tissue morcellation and removal time, of two commercially available FDA-approved morcellators: the VersaCut and the Piranha in subjects undergoing HoLEP procedure for benign prostatic…
- Trial name
- NCT02195622
- Testing
- Lumenis VersaCut Morcellator, Wolf Piranha Morcellator
- Where
- United States
- Volunteers
- 74 people
- Sponsor
- Indiana Kidney Stone Institute